⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CUE News
Cue Biopharma, Inc.
Form 8-K
sec.gov
CUE
Cue Biopharma Announces $30 Million Private Placement
globenewswire.com
CUE
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
globenewswire.com
CUE
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma Announces 1-for-30 Reverse Stock Split
globenewswire.com
CUE
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
globenewswire.com
CUE
Form 8-K
sec.gov
CUE